Development of a lipopolysaccharide-targeted peptide mimic vaccine against Q fever

Journal of Immunology

Volumn 189, Issue 10, 2012, Pages 4909-4920

  Peng, Ying ^a   Zhang, Yan ^a   Mitchell, William J ^a   Zhang, Guoquan ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; EPITOPE; IMMUNOGLOBULIN G; KEYHOLE LIMPET HEMOCYANIN; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY 1E4; Q FEVER VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; BACTERIAL IMMUNITY; BINDING AFFINITY; BIOPANNING; CONTROLLED STUDY; DRUG STRUCTURE; FEASIBILITY STUDY; FEMALE; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOPROPHYLAXIS; IN VIVO STUDY; INFECTION CONTROL; INFECTION PREVENTION; MOLECULAR CLONING; MOLECULAR DOCKING; MOLECULAR INTERACTION; MOLECULAR LIBRARY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; PRIORITY JOURNAL; Q FEVER; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BACTERIAL VACCINES; BIOMIMETIC MATERIALS; COXIELLA BURNETII; EPITOPES; HUMANS; IMMUNIZATION; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; PEPTIDE LIBRARY; Q FEVER; VACCINES, SYNTHETIC;

EID: 84868555661     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201622     Document Type: Article

References (45)

1. Angelakis, E., and D. Raoult. 2010. Q fever. Vet. Microbiol. 140: 297-309.
2. Bell, J. F., D. B. Lackman, A. Meis, and W. J. Hadlow. 1964. Recurrent reaction of site of Q fever vaccination in a sensitized person. Mil. Med. 129: 591-595.
3. Marmion, B. P., R. A. Ormsbee, M. Kyrkou, J. Wright, D. Worswick, S. Cameron, A. Esterman, B. Feery, and W. Collins. 1984. Vaccine prophylaxis of abattoir-associated Q fever. Lancet 324: 1411-1414.
4. Ackland, J. R., D. A. Worswick, and B. P. Marmion. 1994. Vaccine prophylaxis of Q fever: a follow-up study of the efficacy of Q-Vax (CSL) 1985-1990. Med. J. Aust. 160: 704-708.
5. Stoker, M. G., and P. Fiset. 1956. Phase variation of the Nine Mile and other strains of Rickettsia burneti. Can. J. Microbiol. 2: 310-321.
6. Amano, K., and J. C. Williams. 1984. Chemical and immunological characterization of lipopolysaccharides from phase I and phase II Coxiella burnetii. J. Bacteriol. 160: 994-1002.
7. Amano, K., J. C. Williams, S. R. Missler, and V. N. Reinhold. 1987. Structure and biological relationships of Coxiella burnetii lipopolysaccharides. J. Biol. Chem. 262: 4740-4747.
8. Ormsbee, R. A., E. J. Bell, D. B. Lackman, and G. Tallent. 1964. The influence of phase on the protective potency of Q fever vaccine. J. Immunol. 92: 404-412.
9. Zhang, G., K. E. Russell-Lodrigue, M. Andoh, Y. Zhang, L. R. Hendrix, and J. E. Samuel. 2007. Mechanisms of vaccine-induced protective immunity against Coxiella burnetii infection in BALB/c mice. J. Immunol. 179: 8372-8380.
10. Hackstadt, T., M. G. Peacock, P. J. Hitchcock, and R. L. Cole. 1985. Lipo-polysaccharide variation in Coxiella burnetti: intrastrain heterogeneity in structure and antigenicity. Infect. Immun. 48: 359-365.
11. Williams, J. C., T. A. Hoover, D. M. Waag, N. Banerjee-Bhatnagar, C. R. Bolt, and G. H. Scott. 1990. Antigenic structure of Coxiella burnetii: a comparison of lipopolysaccharide and protein antigens as vaccines against Q fever. Ann. N. Y. Acad. Sci. 590: 370-380.
12. De Bolle, X., T. Laurent, A. Tibor, F. Godfroid, V. Weynants, J. J. Letesson, and P. Mertens. 1999. Antigenic properties of peptidic mimics for epitopes of the lipopolysaccharide from Brucella. J. Mol. Biol. 294: 181-191.
13. Dharmasena, M. N., D. A. Jewell, and R. K. Taylor. 2007. Development of peptide mimics of a protective epitope of Vibrio cholerae Ogawa O-antigen and investigation of the structural basis of peptide mimicry. J. Biol. Chem. 282: 33805-33816.
14. Fleuridor, R., A. Lees, and L. Pirofski. 2001. A cryptococcal capsular poly-saccharide mimotope prolongs the survival of mice with Cryptococcus neofor-mans infection. J. Immunol. 166: 1087-1096.
15. Harris, S. L., L. Craig, J. S. Mehroke, M. Rashed, M. B. Zwick, K. Kenar, E. J. Toone, N. Greenspan, F. I. Auzanneau, J. R. Marino-Albernas, et al. 1997. Exploring the basis of peptide-carbohydrate crossreactivity: evidence for discrimination by peptides between closely related anti-carbohydrate antibodies. Proc. Natl. Acad. Sci. USA 94: 2454-2459.
16. Hou, Y., and X. X. Gu. 2003. Development of peptide mimotopes of lipo-oligosaccharide from nontypeable Haemophilus influenzae as vaccine candidates. J. Immunol. 170: 4373-4379.
17. Lesinski, G. B., S. L. Smithson, N. Srivastava, D. Chen, G. Widera, and M. A. Westerink. 2001. A DNA vaccine encoding a peptide mimic of Streptococcus pneumoniae serotype 4 capsular polysaccharide induces specific anti-carbohydrate antibodies in Balb/c mice. Vaccine 19: 1717-1726.
18. Phalipon, A., A. Folgori, J. Arondel, G. Sgaramella, P. Fortugno, R. Cortese, P. J. Sansonetti, and F. Felici. 1997. Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics. Eur. J. Immunol. 27: 2620-2625.
19. Monzavi-Karbassi, B., G. Cunto-Amesty, P. Luo, and T. Kieber-Emmons. 2002. Peptide mimotopes as surrogate antigens of carbohydrates in vaccine discovery. Trends Biotechnol. 20: 207-214.
20. Ho, T., K. K. Htwe, N. Yamasaki, G. Q. Zhang, M. Ogawa, T. Yamaguchi, H. Fukushi, and K. Hirai. 1995. Isolation of Coxiella burnetii from dairy cattle and ticks, and some characteristics of the isolates in Japan. Microbiol. Immunol. 39: 663-671.
21. Williams, J. C., and J. L. Cantrell. 1982. Biological and immunological properties of Coxiella burnetii vaccines in C57BL/10ScN endotoxin-nonresponder mice. Infect. Immun. 35: 1091-1102.
22. Reading, C. L. 1982. Theory and methods for immunization in culture and monoclonal antibody production. J. Immunol. Methods 53: 261-291.
23. Savitt, A. G., P. Mena-Taboada, G. Monsalve, and J. L. Benach. 2009. Franci-sella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy. Clin. Vaccine Immunol. 16: 414-422.
24. Zhang, G. Q., A. Hotta, T. Ho, T. Yamaguchi, H. Fukushi, and K. Hirai. 1998. Evaluation of a recombinant 27-kDa outer membrane protein of Coxiella bur-netii as an immunodiagnostic reagent. Microbiol. Immunol. 42: 423-428.
25. Zhang, G., and J. E. Samuel. 2004. Vaccines against Coxiella infection. Expert Rev. Vaccines 3: 577-584.
26. Brennan, R. E., and J. E. Samuel. 2003. Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay. J. Clin. Microbiol. 41: 1869-1874.
27. Zhang, G. Q., and J. E. Samuel. 2003. Identification and cloning potentially protective antigens of Coxiella burnetii using sera from mice experimentally infected with Nine Mile phase I. Ann. N. Y. Acad. Sci. 990: 510-520.
28. Orlandi, R., D. H. Güssow, P. T. Jones, and G. Winter. 1989. Cloning immu-noglobulin variable domains for expression by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 86: 3833-3837.
29. Phalipon, A., C. Costachel, C. Grandjean, A. Thuizat, C. Guerreiro, M. Tanguy, F. Nato, B. Vulliez-Le Normand, F. Bélot, K. Wright, et al. 2006. Characterization of functional oligosaccharide mimics of the Shigella flexneri serotype 2a O-antigen: implications for the development of a chemically defined glyco-conjugate vaccine. J. Immunol. 176: 1686-1694.
30. Wang, Z., M. Raifu, M. Howard, L. Smith, D. Hansen, R. Goldsby, and D. Ratner. 2000. Universal PCR amplification of mouse immunoglobulin gene variable regions: the design of degenerate primers and an assessment of the effect of DNA polymerase 39 to 59 exonuclease activity. J. Immunol. Methods 233: 167-177.
31. Moe, G. R., A. Dave, and D. M. Granoff. 2006. Molecular analysis of anti-N-propionyl Neisseria meningitidis group B polysaccharide monoclonal antibodies. Mol. Immunol. 43: 1424-1431.
32. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157: 105-132.
33. Hotta, A., M. Kawamura, H. To, M. Andoh, T. Yamaguchi, H. Fukushi, K. Amano, and K. Hirai. 2003. Use of monoclonal antibodies to lipopolysaccharide for an-tigenic analysis of Coxiella burnetii. J. Clin. Microbiol. 41: 1747-1749.
34. Hotta, A., M. Kawamura, H. To, M. Andoh, T. Yamaguchi, H. Fukushi, and K. Hirai. 2002. Phase variation analysis of Coxiella burnetii during serial passage in cell culture by use of monoclonal antibodies. Infect. Immun. 70: 4747-4749.
35. Hotta, A., G. Q. Zhang, M. Andoh, T. Yamaguchi, H. Fukushi, and K. Hirai. 2004. Use of monoclonal antibodies for analyses of Coxiella burnetii major antigens. J. Vet. Med. Sci. 66: 1289-1291.
36. Palkovicova, K., R. Ihnatko, P. Vadovic, E. Betinova, L. Skultety, D. Frangoulidis, and R. Toman. 2009. A monoclonal antibody specific for a unique biomarker, virenose, in a lipopolysaccharide of Coxiella burnetii. Clin. Microbiol. Infect. 15(Suppl. 2): 183-184.
37. Andoh, M., G. Zhang, K. E. Russell-Lodrigue, H. R. Shive, B. R. Weeks, and J. E. Samuel. 2007. T cells are essential for bacterial clearance, and gamma interferon, tumor necrosis factor alpha, and B cells are crucial for disease development in Coxiella burnetii infection in mice. Infect. Immun. 75: 3245-3255.
38. Deroo, S., and C. P. Muller. 2001. Antigenic and immunogenic phage displayed mimotopes as substitute antigens: applications and limitations. Comb. Chem. High Throughput Screen. 4: 75-110.
39. Valadon, P., G. Nussbaum, L. F. Boyd, D. H. Margulies, and M. D. Scharff. 1996. Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans. J. Mol. Biol. 261: 11-22.
40. Oldenburg, K. R., D. Loganathan, I. J. Goldstein, P. G. Schultz, and M. A. Gallop. 1992. Peptide ligands for a sugar-binding protein isolated from a random peptide library. Proc. Natl. Acad. Sci. USA 89: 5393-5397.
41. Scott, J. K., D. Loganathan, R. B. Easley, X. Gong, and I. J. Goldstein. 1992. A family of concanavalin A-binding peptides from a hexapeptide epitope library. Proc. Natl. Acad. Sci. USA 89: 5398-5402.
42. Westerink, M. A., A. A. Campagnari, P. Giardina, and M. A. Apicella. 1994. Antiidiotype antibodies as surrogates for polysaccharide vaccines. Ann. N. Y. Acad. Sci. 730: 209-216.
43. Wu, Y., Q. Zhang, D. Sales, A. E. Bianco, and A. Craig. 2010. Vaccination with peptide mimotopes produces antibodies recognizing bacterial capsular poly-saccharides. Vaccine 28: 6425-6435.
44. Van Regenmortel, M. H. 2009. What is a B-cell epitope? Methods Mol. Biol. 524: 3-20.
45. Luo, P., G. Canziani, G. Cunto-Amesty, and T. Kieber-Emmons. 2000. A molecular basis for functional peptide mimicry of a carbohydrate antigen. J. Biol. Chem. 275: 16146-16154.